혈액 스크리닝 시장(2026-2030년)

The global blood screening market is forecasted to grow by USD 1363.9 mn during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global blood screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases and global blood safety mandates, rapid technological advancements in molecular diagnostics and automation, rising volume of blood donations and demand for transfusion-dependent therapies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global blood screening market is segmented as below:

By Component

• Reagents and kits
• Instruments
• Software and services

By End-User

• Blood bank
• Hospitals

By Technology

• NAT
• ELISA
• Rapid tests
• Western blotting
• NGS

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the increasing emphasis on early identification of emerging blood-borne pathogens as one of the prime reasons driving the global blood screening market growth during the next few years. Also, adoption of advanced high-throughput automation and nucleic acid testing and expansion of global healthcare infrastructure and regulatory compliance mandates will lead to sizable demand in the market.

The report on the global blood screening market covers the following areas:

• Global blood screening market sizing
• Global blood screening market forecast
• Global blood screening market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global blood screening market vendors that include Abbott Laboratories, AliveDx, Beckman Coulter Inc., Bio Rad Laboratories Inc., CTK Biotech Inc., DiaSorin SpA, Erba Mannheim, F. Hoffmann La Roche Ltd., Fortress Diagnostics, Fujirebio Holdings Inc., Grifols SA, Hologic Inc., J. Mitra and Co. Pvt. Ltd., Lorne Laboratories Ltd., Maccura Biotechnology Co. Ltd., MTC In Vitro, QuidelOrtho Corp., Shenzhen Mindray Co. Ltd., Snibe Co.Ltd., Transasia Bio Medicals Ltd.. Also, the global blood screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Component
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Blood Screening Market 2020 - 2024
  • Historic Market Size - Data Table on Global Blood Screening Market 2020 - 2024 ($ million)
• 5.2 Component segment analysis 2020 - 2024
  • Historic Market Size - Component Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Blood Screening Market
• 6.2 Impact of Geopolitical Conflict on Global Blood Screening Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Component

• 8.1 Market segments
• 8.2 Comparison by Component
• 8.3 Reagents and kits - Market size and forecast 2025-2030
• 8.4 Instruments - Market size and forecast 2025-2030
• 8.5 Software and services - Market size and forecast 2025-2030
• 8.6 Market opportunity by Component
  • Market opportunity by Component ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Blood bank - Market size and forecast 2025-2030
• 9.4 Hospitals - Market size and forecast 2025-2030
• 9.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 NAT - Market size and forecast 2025-2030
• 10.4 ELISA - Market size and forecast 2025-2030
• 10.5 Rapid tests - Market size and forecast 2025-2030
• 10.6 Western blotting - Market size and forecast 2025-2030
• 10.7 NGS - Market size and forecast 2025-2030
• 10.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 Turkey - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing prevalence of infectious diseases and global blood safety mandates
  • Rapid technological advancements in molecular diagnostics and automation
  • Rising volume of blood donations and demand for transfusion-dependent therapies
• 13.2 Market challenges
  • High implementation and operational expenses as barrier to entry
  • Stringent regulatory frameworks and complex compliance landscapes
  • Limitations in technical expertise and laboratory infrastructure
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Increasing emphasis on early identification of emerging blood-borne pathogens
  • Adoption of advanced high-throughput automation and nucleic acid testing
  • Expansion of global healthcare infrastructure and regulatory compliance mandates

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 AliveDx
  • AliveDx - Overview
  • AliveDx - Product / Service
  • AliveDx - Key offerings
  • SWOT
• 15.6 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.8 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 15.9 Erba Mannheim
  • Erba Mannheim - Overview
  • Erba Mannheim - Product / Service
  • Erba Mannheim - Key offerings
  • SWOT
• 15.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.11 Fortress Diagnostics
  • Fortress Diagnostics - Overview
  • Fortress Diagnostics - Product / Service
  • Fortress Diagnostics - Key offerings
  • SWOT
• 15.12 Fujirebio Holdings Inc.
  • Fujirebio Holdings Inc. - Overview
  • Fujirebio Holdings Inc. - Product / Service
  • Fujirebio Holdings Inc. - Key offerings
  • SWOT
• 15.13 Grifols SA
  • Grifols SA - Overview
  • Grifols SA - Business segments
  • Grifols SA - Key offerings
  • Grifols SA - Segment focus
  • SWOT
• 15.14 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Product / Service
  • Hologic Inc. - Key offerings
  • SWOT
• 15.15 Maccura Biotechnology Co. Ltd.
  • Maccura Biotechnology Co. Ltd. - Overview
  • Maccura Biotechnology Co. Ltd. - Product / Service
  • Maccura Biotechnology Co. Ltd. - Key offerings
  • SWOT
• 15.16 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
• 15.17 Shenzhen Mindray Co. Ltd.
  • Shenzhen Mindray Co. Ltd. - Overview
  • Shenzhen Mindray Co. Ltd. - Business segments
  • Shenzhen Mindray Co. Ltd. - Key offerings
  • Shenzhen Mindray Co. Ltd. - Segment focus
  • SWOT
• 15.18 Transasia Bio Medicals Ltd.
  • Transasia Bio Medicals Ltd. - Overview
  • Transasia Bio Medicals Ltd. - Product / Service
  • Transasia Bio Medicals Ltd. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations